Search results (Hint: Try the special 'Search Parts' system on the main page)

  • ...n adaptive immune system in prokaryotes. While the specific ‘adaptive’ nature of this immunity is still under investigation, it is known that exogenous D <strong>Abstract</strong>: In nature, there exist a variety of magnetotactic bacteria. Recently, it was reported
    43 KB (6,626 words) - 15:52, 16 July 2020
  • ..., D. et al. FLASH assembly of TALENs for high-throughput genome editing. ''Nature Biotechnology'' 30, 460–465 (2012). ...sequence-specific TAL effectors for modulating mammalian transcription. ''Nature biotechnology'' 29, 149–153 (2011).
    3 KB (339 words) - 21:13, 26 October 2012
  • ..., D. et al. FLASH assembly of TALENs for high-throughput genome editing. ''Nature Biotechnology'' 30, 460–465 (2012). ...sequence-specific TAL effectors for modulating mammalian transcription. ''Nature biotechnology'' 29, 149–153 (2011).
    3 KB (345 words) - 12:53, 29 October 2012
  • ..., D. et al. FLASH assembly of TALENs for high-throughput genome editing. ''Nature Biotechnology'' 30, 460–465 (2012). ...sequence-specific TAL effectors for modulating mammalian transcription. ''Nature biotechnology'' 29, 149–153 (2011).
    2 KB (271 words) - 09:47, 31 October 2012
  • ..., D. et al. FLASH assembly of TALENs for high-throughput genome editing. ''Nature Biotechnology'' 30, 460–465 (2012). ...sequence-specific TAL effectors for modulating mammalian transcription. ''Nature biotechnology'' 29, 149–153 (2011).
    2 KB (272 words) - 09:47, 31 October 2012
  • ..., D. et al. FLASH assembly of TALENs for high-throughput genome editing. ''Nature Biotechnology'' 30, 460–465 (2012). ...sequence-specific TAL effectors for modulating mammalian transcription. ''Nature biotechnology'' 29, 149–153 (2011).
    3 KB (379 words) - 10:01, 31 October 2012
  • ..., D. et al. FLASH assembly of TALENs for high-throughput genome editing. ''Nature Biotechnology'' 30, 460–465 (2012). ...sequence-specific TAL effectors for modulating mammalian transcription. ''Nature biotechnology'' 29, 149–153 (2011).
    2 KB (295 words) - 12:33, 29 October 2012
  • ...e.jpg|200px|thumb|left|Figure 1 The 3D structure of tcdA1. Copyright 2013, Nature Publishing Group.]] ...parison between pre-pore state and pore state of tcdA1(2). Copyright 2014, Nature Publishing Group]]
    7 KB (1,119 words) - 10:37, 18 September 2015
  • ...e.jpg|200px|thumb|left|Figure 1 The 3D structure of TcdA1. Copyright 2013, Nature Publishing Group.]] ...between pre-pore state and pore state of tcdA1(<i>2</i>).. Copyright 2014, Nature Publishing Group]]
    4 KB (562 words) - 09:39, 18 September 2015
  • ...et genomic sites using processive base deaminase fusions blocked by dCas9. Nature Communications (2020) 11: 6436. ...ase editing enables ''in vivo'' mutagenesis and rapid protein engineering. Nature Communications (2021) 12: 1579.
    24 KB (3,599 words) - 23:45, 21 October 2021
  • ...et genomic sites using processive base deaminase fusions blocked by dCas9. Nature Communications (2020) 11: 6436. ...ase editing enables ''in vivo'' mutagenesis and rapid protein engineering. Nature Communications (2021) 12: 1579.
    24 KB (3,606 words) - 23:14, 21 October 2021
  • ...et genomic sites using processive base deaminase fusions blocked by dCas9. Nature Communications (2020) 11: 6436. ...ase editing enables ''in vivo'' mutagenesis and rapid protein engineering. Nature Communications (2021) 12: 1579.
    24 KB (3,606 words) - 23:19, 21 October 2021
  • ...et genomic sites using processive base deaminase fusions blocked by dCas9. Nature Communications (2020) 11: 6436. ...ase editing enables ''in vivo'' mutagenesis and rapid protein engineering. Nature Communications (2021) 12: 1579.
    24 KB (3,606 words) - 23:22, 21 October 2021
  • ...et genomic sites using processive base deaminase fusions blocked by dCas9. Nature Communications (2020) 11: 6436. ...ase editing enables ''in vivo'' mutagenesis and rapid protein engineering. Nature Communications (2021) 12: 1579.
    24 KB (3,606 words) - 23:28, 21 October 2021
  • ...et genomic sites using processive base deaminase fusions blocked by dCas9. Nature Communications (2020) 11: 6436. ...ase editing enables ''in vivo'' mutagenesis and rapid protein engineering. Nature Communications (2021) 12: 1579.
    24 KB (3,608 words) - 23:37, 21 October 2021
  • ...et genomic sites using processive base deaminase fusions blocked by dCas9. Nature Communications (2020) 11: 6436. ...ase editing enables ''in vivo'' mutagenesis and rapid protein engineering. Nature Communications (2021) 12: 1579.
    24 KB (3,608 words) - 22:57, 21 October 2021
  • ...et genomic sites using processive base deaminase fusions blocked by dCas9. Nature Communications (2020) 11: 6436. ...ase editing enables ''in vivo'' mutagenesis and rapid protein engineering. Nature Communications (2021) 12: 1579.
    24 KB (3,607 words) - 23:01, 21 October 2021
  • ...et genomic sites using processive base deaminase fusions blocked by dCas9. Nature Communications (2020) 11: 6436. ...ase editing enables ''in vivo'' mutagenesis and rapid protein engineering. Nature Communications (2021) 12: 1579.
    24 KB (3,606 words) - 23:36, 21 October 2021
  • ...et genomic sites using processive base deaminase fusions blocked by dCas9. Nature Communications (2020) 11: 6436. ...ase editing enables ''in vivo'' mutagenesis and rapid protein engineering. Nature Communications (2021) 12: 1579.
    24 KB (3,606 words) - 23:39, 21 October 2021
  • ...et genomic sites using processive base deaminase fusions blocked by dCas9. Nature Communications (2020) 11: 6436. ...ase editing enables ''in vivo'' mutagenesis and rapid protein engineering. Nature Communications (2021) 12: 1579.
    24 KB (3,605 words) - 00:39, 22 October 2021

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)